Litcius/Paper detail

Is There a Benefit to Adjuvant Chemotherapy in Resected, Early Stage Pancreatic Ductal Adenocarcinoma?

Kevin M. Turner, Aaron M. Delman, Allison M. Ammann, Davendra Sohal, Olugbenga Olowokure, Kyuran A. Choe, Milton T. Smith, Jordan Kharofa, Syed A. Ahmad, Gregory C. Wilson, Sameer H. Patel

2022Annals of Surgical Oncology20 citationsDOI

Topics & Concepts

MedicineSurgical oncologyStage (stratigraphy)Internal medicineLymphovascular invasionPancreatic cancerChemotherapyPancreatic ductal adenocarcinomaOncologyAdenocarcinomaAdjuvant therapyNeoadjuvant therapyResection marginCohortCancerGastroenterologySurgeryBreast cancerResectionMetastasisBiologyPaleontologyPancreatic and Hepatic Oncology ResearchCholangiocarcinoma and Gallbladder Cancer StudiesEsophageal Cancer Research and Treatment
Is There a Benefit to Adjuvant Chemotherapy in Resected, Early Stage Pancreatic Ductal Adenocarcinoma? | Litcius